tiprankstipranks
Cormedix (CRMD)
NASDAQ:CRMD
Holding CRMD?
Track your performance easily

Cormedix (CRMD) Income Statement

1,229 Followers

Cormedix Income Statement

Last quarter (Q3 2024), Cormedix's total revenue was $11.46M, an increase of Infinity% from the same quarter last year. In Q3, Cormedix's net income was $-2.78M. See Cormedix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 12.26M-$ 65.41K$ 190.94K$ 239.23K$ 283.27K
Cost of Revenue
$ 2.01M-$ 3.73K$ 148.94K$ 204.85K$ 373.23K
Gross Profit
$ 10.25M-$ 61.67K$ 42.00K$ 34.38K$ -89.97K
Operating Expense
$ 61.21M$ 48.96M$ 30.69M$ 29.48M$ 27.26M$ 20.92M
Operating Income
$ -50.96M$ -48.96M$ -30.62M$ -29.44M$ -27.22M$ -21.01M
Net Non Operating Interest Income Expense
$ 2.97M$ 2.65M$ 299.50K$ -1.54K$ 82.84K$ -464.82K
Other Income Expense
$ -498.77K$ -28.99K$ 37.15K-$ 204.85K$ -1.76K
Pretax Income
$ -47.54M$ -46.34M$ -30.29M$ -29.46M$ -27.20M$ -21.49M
Tax Provision
$ -1.39M-$ -585.62K$ -1.25M$ -5.17M$ -5.06M
Earnings From Equity Interest Net Of Tax
-----$ -369.50K
Net Income Common Stockholders
$ -46.15M$ -46.34M$ -29.70M$ -28.21M$ -22.03M$ -59.97M
Basic EPS
$ -0.80$ -0.91$ -0.74$ -0.75$ -0.77-
Diluted EPS
$ -0.80$ -0.91$ -0.74$ -0.75$ -0.77$ -1.80
Basic Average Shares
$ 231.55M$ 50.90M$ 40.27M$ 37.67M$ 28.56M$ 24.15M
Diluted Average Shares
$ 231.55M$ 50.90M$ 40.27M-$ 28.56M$ 24.15M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 63.22M$ 48.96M$ 30.69M$ 29.63M$ 27.46M$ 21.29M
Net Income From Continuing And Discontinued Operation
$ -46.15M$ -46.34M$ -29.70M$ -28.21M$ -22.03M$ -32.87M
Normalized Income
$ -28.41M$ -36.61M-$ -30.71M--
Interest Expense
------
EBIT
$ -47.52M$ -46.30M$ -30.26M$ -29.44M$ -27.16M$ -20.71M
EBITDA
$ -47.22M$ -46.23M$ -30.18M$ -29.38M$ -27.00M$ -20.32M
Currency in USD

Cormedix Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis